GSK have stated that they have sold 600m pounds of Relenza since...

GSK have stated that they have sold 600m pounds of Relenza since the outbreak of the swine flu virus so that's:

600m divided by .56 to convert to Australian dollars by 7% for BTA share = about $75m less the about $9m paid last quarter that comes to about $66m.

Now I have used rough figures but if GSK report around $40m for this quarter then BTA will rocket.

That does not included the Lani deal or the 11c dividend.

I bought some more today left the computer after lunch as Tuesday is my special grandson and I walk day so put in a bid for $3.10 and did not expect to get them but got them easily wow $2.88 hey.

Let see what tommorrow brings but one thing is sure after the GSK quarterly results on the 28/10/09 then we should have a big jump.

I do own BTA and obviously biased so DYOR.